Supplementary figures for Cladribine (2-CdA) improves cutaneous manifestations, DLQI and MC-QoL of patients with mastocytosis
Published: 9 January 2024| Version 1 | DOI: 10.17632/tk68xz7nmh.1
Contributors:
Hélène Bugaut, Hervé Maillard, Caroline Jacobzone Leveque, , , , , , , , Stéphane BareteDescription
This set of supplementary figures illustrates additional content of the article "Cladribine (2-CdA) improves cutaneous manifestations, DLQI and MC-QoL of patients with mastocytosis"
Files
Institutions
Assistance Publique - Hopitaux de Paris, Sorbonne Universite, Hopitaux Universitaires Pitie Salpetriere-Charles Foix
Categories
Dermatology, Cladribine, Systemic Mastocytosis, Mastocytosis